Serum procalcitonin as a marker of neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) [PDF]
Neonatal Intrahepatic Cholestasis (NICCD), as the early-age stage of Citrin deficiency involving liver dysfunction, lacks efficient diagnostic markers. Procalcitonin (PCT) has been identified as a biomarker for infection as well as various organ damage.
Li Shuangjie, Ying Yu, Wenxian OUYANG
exaly +6 more sources
Clinical landscape of citrin deficiency: A global perspective on a multifaceted condition [PDF]
Abstract Citrin deficiency is an autosomal recessive disorder caused by a defect of citrin resulting from mutations in SLC25A13. The clinical manifestation is very variable and comprises three types: neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD: OMIM 605814), post‐NICCD including failure to thrive and dyslipidemia caused by ...
Johannes Häberle +2 more
exaly +5 more sources
Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) and clinical implications [PDF]
Background Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) has high prevalence in East Asia, and has been reported in other parts of the world. NICCD is also the most common form of genetic cholestasis among East Asians.
She Wang, Kuerbanjiang Abuduxikuer
exaly +5 more sources
Identification of a novel splicing mutation in the SLC25A13 gene from a patient with NICCD: a case report [PDF]
Background Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is an autosomal recessive disorder and one of the most common inherent causes of cholestatic jaundice in Asian infants.
Shihong Cui, Xiaoan Zhang, Linlin Zhang
exaly +5 more sources
Deciphering the Mutational Background in Citrin Deficiency Through a Nationwide Study in Japan and Literature Review. [PDF]
Citrin deficiency (CD) is an autosomal recessive disorder caused by the absence or dysfunction of the mitochondrial transporter citrin, resulting from mutations in SLC25A13. The disease presents with age‐dependent clinical manifestations: neonatal intrahepatic cholestasis caused by CD (NICCD), failure to thrive and dyslipidemia by CD (FTTDCD), and an ...
Kido J +7 more
europepmc +5 more sources
Blood glucose and insulin and correlation of SLC25A13 mutations with biochemical changes in NICCD patients [PDF]
Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is a hereditary metabolic disease arising from biallelic mutations of SLC25A13. This study aimed to explore the characteristics of fasting blood glucose (FBG), fasting insulin (FINS) and C-peptide (C-P) levels in NICCD infants, analyze their SLC25A13 genetic mutations and further ...
Chun-Ting, Lu +4 more
openaire +3 more sources
Neonatal intrahepatic cholestasis caused by citrin deficiency: prevalence and
Background The most common causes of cholestatic jaundice are biliary atresia and idiopathic neonatal hepatitis (INH). Specific disorders underlying INH, such as various infectious and metabolic causes, including neonatal intrahepatic cholestasis caused ...
Treepongkaruna Suporn +7 more
doaj +3 more sources
Citrullinemia is the earliest identifiable biochemical abnormality in neonates with intrahepatic cholestasis due to a citrin deficiency (NICCD) and it has been included in newborn screening panels using tandem mass spectrometry. However, only one neonate
Hiroko Shigetomi +3 more
doaj +2 more sources
Background: Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is a rare autosomal recessive disease. The incidence of citrin deficiency is estimated between 1/10,000 and 1/20,000 in Taiwan. Case report: This report describes a case of
Shu-Wei Hu +5 more
doaj +2 more sources
Background and objectives: This retrospective study analysed a case series of subjects with citrin deficiency, and aims to present the molecular and clinical characterization of this disease in the Hong Kong Chinese population for the first time ...
S.C. Chong +7 more
doaj +2 more sources

